Colgate-Palmolive Company (NYSE:CL) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Colgate-Palmolive Company (NYSE:CL) have earned an average rating of “Moderate Buy” from the seventeen research firms that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $94.3750.

CL has been the topic of a number of analyst reports. Raymond James Financial dropped their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Morgan Stanley raised their price target on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Jefferies Financial Group increased their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Finally, UBS Group lifted their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th.

Colgate-Palmolive Price Performance

Shares of CL opened at $96.61 on Monday. The business’s 50-day moving average is $83.80 and its two-hundred day moving average is $81.84. The company has a market capitalization of $77.87 billion, a P/E ratio of 36.87, a P/E/G ratio of 4.36 and a beta of 0.29. Colgate-Palmolive has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the prior year, the business earned $0.91 earnings per share. The company’s revenue was up 5.8% compared to the same quarter last year. Research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a $0.52 dividend. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is 79.39%.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Zacks Research raised several forward earnings estimates (including FY2026 to $3.89 and FY2027 to $4.15) and lifted some quarterly targets, signaling better-than-expected longer‑term earnings progression — supportive for valuation upgrades. Zacks estimate revisions (MarketBeat)
• Positive Sentiment: Major brokers have recently raised targets and stance (Morgan Stanley to $100/overweight; JPMorgan to $97/overweight; Wells Fargo nudged its target higher), which can attract buying and help lift the stock. Analyst target changes (MarketBeat)
• Positive Sentiment: Media/TV mention — Jim Cramer highlighted Colgate’s strong growth, a visible endorsement that can spur retail interest and intraday buying. Cramer: Colgate had great growth
• Neutral Sentiment: Dividend and shareholder returns remain intact — Colgate paid the routine $0.52 quarterly dividend (annualized $2.08, ~2.2% yield); supportive for income investors but already priced in for many holders. Dividend announcement (MarketBeat)
• Neutral Sentiment: Institutional activity shows small incremental buys by several funds in Q4 (some managers added to positions), indicating steady institutional ownership (~80% held by institutions). That steady demand can limit downside but isn’t a near-term catalyst. Institutional flows (MarketBeat)
• Negative Sentiment: Significant insider selling: COO Panagiotis Tsourapas sold 15,000 shares (~$1.47M at ~$97.81), reducing his stake materially. Large insider sales can concern investors about timing or personal liquidity needs and may create short‑term selling pressure. COO Panagiotis Tsourapas sells 15,000 shares
• Negative Sentiment: Another insider (John Hazlin) sold ~20,989 shares for ~$1.98M. Multiple insider sales over days amplify the negative signal versus isolated transactions. Investors should watch future filings for patterns. Insider sale: John Hazlin

Insiders Place Their Bets

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 35,000 shares of the stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $985,363.15. This trade represents a 77.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the sale, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 184,683 shares of company stock worth $17,486,693. Corporate insiders own 0.41% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jacobi Capital Management LLC increased its stake in Colgate-Palmolive by 5.8% during the 4th quarter. Jacobi Capital Management LLC now owns 10,543 shares of the company’s stock worth $833,000 after buying an additional 581 shares in the last quarter. CreativeOne Wealth LLC boosted its stake in shares of Colgate-Palmolive by 7.6% in the fourth quarter. CreativeOne Wealth LLC now owns 16,087 shares of the company’s stock worth $1,271,000 after acquiring an additional 1,140 shares during the last quarter. Kestra Advisory Services LLC increased its position in shares of Colgate-Palmolive by 2.2% during the fourth quarter. Kestra Advisory Services LLC now owns 40,463 shares of the company’s stock worth $3,197,000 after purchasing an additional 885 shares in the last quarter. Ontario Teachers Pension Plan Board raised its stake in Colgate-Palmolive by 7.3% in the 4th quarter. Ontario Teachers Pension Plan Board now owns 40,234 shares of the company’s stock valued at $3,179,000 after purchasing an additional 2,732 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in Colgate-Palmolive by 2.2% during the 4th quarter. The Manufacturers Life Insurance Company now owns 816,427 shares of the company’s stock worth $64,689,000 after purchasing an additional 17,771 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.